196 related articles for article (PubMed ID: 32646242)
1. Zinc Level and Its Role in Recurrent
Parvataneni S; Dasari AR
J Investig Med High Impact Case Rep; 2020; 8():2324709620941315. PubMed ID: 32646242
[No Abstract] [Full Text] [Related]
2. An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.
Tomkovich S; Taylor A; King J; Colovas J; Bishop L; McBride K; Royzenblat S; Lesniak NA; Bergin IL; Schloss PD
mSphere; 2021 Oct; 6(5):e0062921. PubMed ID: 34585964
[TBL] [Abstract][Full Text] [Related]
3. Genetic Association Reveals Protection against Recurrence of
Shen J; Mehrotra DV; Dorr MB; Zeng Z; Li J; Xu X; Nickle D; Holzinger ER; Chhibber A; Wilcox MH; Blanchard RL; Shaw PM
mSphere; 2020 May; 5(3):. PubMed ID: 32376702
[TBL] [Abstract][Full Text] [Related]
4. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
[TBL] [Abstract][Full Text] [Related]
5. Coinfection and Emergence of Rifamycin Resistance during a Recurrent Clostridium difficile Infection.
Stevenson EC; Major GA; Spiller RC; Kuehne SA; Minton NP
J Clin Microbiol; 2016 Nov; 54(11):2689-2694. PubMed ID: 27558181
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
[No Abstract] [Full Text] [Related]
7. The role of zinc and nutritional immunity in Clostridium difficile infection.
Zackular JP; Skaar EP
Gut Microbes; 2018; 9(5):469-476. PubMed ID: 29533126
[TBL] [Abstract][Full Text] [Related]
8. Diarrhoeal events can trigger long-term Clostridium difficile colonization with recurrent blooms.
VanInsberghe D; Elsherbini JA; Varian B; Poutahidis T; Erdman S; Polz MF
Nat Microbiol; 2020 Apr; 5(4):642-650. PubMed ID: 32042128
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study.
Vickers RJ; Tillotson GS; Nathan R; Hazan S; Pullman J; Lucasti C; Deck K; Yacyshyn B; Maliakkal B; Pesant Y; Tejura B; Roblin D; Gerding DN; Wilcox MH;
Lancet Infect Dis; 2017 Jul; 17(7):735-744. PubMed ID: 28461207
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial spread of Clostridium difficile.
Savage AM; Alford RH
Infect Control; 1983; 4(1):31-3. PubMed ID: 6550579
[TBL] [Abstract][Full Text] [Related]
11. Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence.
Kechagias KS; Chorepsima S; Triarides NA; Falagas ME
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1053-1058. PubMed ID: 31927652
[TBL] [Abstract][Full Text] [Related]
12. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.
Gebhart D; Lok S; Clare S; Tomas M; Stares M; Scholl D; Donskey CJ; Lawley TD; Govoni GR
mBio; 2015 Mar; 6(2):. PubMed ID: 25805733
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.
van Opstal E; Kolling GL; Moore JH; Coquery CM; Wade NS; Loo WM; Bolick DT; Shin JH; Erickson LD; Warren CA
J Infect Dis; 2016 Jul; 214(1):130-9. PubMed ID: 26917573
[TBL] [Abstract][Full Text] [Related]
14. SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
McGovern BH; Ford CB; Henn MR; Pardi DS; Khanna S; Hohmann EL; O'Brien EJ; Desjardins CA; Bernardo P; Wortman JR; Lombardo MJ; Litcofsky KD; Winkler JA; McChalicher CWJ; Li SS; Tomlinson AD; Nandakumar M; Cook DN; Pomerantz RJ; Auninš JG; Trucksis M
Clin Infect Dis; 2021 Jun; 72(12):2132-2140. PubMed ID: 32255488
[TBL] [Abstract][Full Text] [Related]
15. Why Does Clostridium difficile Infection Recur?
Orenstein R; Patron RL; Seville MT
J Am Osteopath Assoc; 2019 May; 119(5):322-326. PubMed ID: 31034070
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection.
Theriot CM; Koenigsknecht MJ; Carlson PE; Hatton GE; Nelson AM; Li B; Huffnagle GB; Z Li J; Young VB
Nat Commun; 2014; 5():3114. PubMed ID: 24445449
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).
Bouza E; Aguado JM; Alcalá L; Almirante B; Alonso-Fernández P; Borges M; Cobo J; Guardiola J; Horcajada JP; Maseda E; Mensa J; Merchante N; Muñoz P; Pérez Sáenz JL; Pujol M; Reigadas E; Salavert M; Barberán J
Rev Esp Quimioter; 2020 Apr; 33(2):151-175. PubMed ID: 32080996
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in the management of recurrent Clostridioides difficile infection.
Mendo-Lopez R; Villafuerte-Gálvez J; White N; Mahoney MV; Kelly CP; Alonso CD
Anaerobe; 2020 Apr; 62():102108. PubMed ID: 31606481
[TBL] [Abstract][Full Text] [Related]
19. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
[TBL] [Abstract][Full Text] [Related]
20. A contemporary review of Clostridioides difficile infections in patients with haematologic diseases.
Dutta D; Jafri F; Stuhr D; Knoll BM; Lim SH
J Intern Med; 2021 Mar; 289(3):293-308. PubMed ID: 32910532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
